321 related articles for article (PubMed ID: 25119316)
1. Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.
Revilla S; Ursulet S; Álvarez-López MJ; Castro-Freire M; Perpiñá U; García-Mesa Y; Bortolozzi A; Giménez-Llort L; Kaliman P; Cristòfol R; Sarkis C; Sanfeliu C
CNS Neurosci Ther; 2014 Nov; 20(11):961-72. PubMed ID: 25119316
[TBL] [Abstract][Full Text] [Related]
2. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
[TBL] [Abstract][Full Text] [Related]
3. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
6. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.
Kanninen K; Heikkinen R; Malm T; Rolova T; Kuhmonen S; Leinonen H; Ylä-Herttuala S; Tanila H; Levonen AL; Koistinaho M; Koistinaho J
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16505-10. PubMed ID: 19805328
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
8. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW
Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
[TBL] [Abstract][Full Text] [Related]
11. Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease.
Petukhova EO; Mukhamedshina YO; Salafutdinov II; Garanina EE; Kaligin MS; Leushina AV; Rizvanov AA; Reis HJ; Palotás A; Zefirov AL; Mukhamedyarov MA
J Alzheimers Dis; 2019; 69(2):443-453. PubMed ID: 30958382
[TBL] [Abstract][Full Text] [Related]
12. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 Overexpression in Mouse Hippocampus Induces Cognitive Enhancement Through Proteostatic and Neurotrophic Mechanisms.
Corpas R; Revilla S; Ursulet S; Castro-Freire M; Kaliman P; Petegnief V; Giménez-Llort L; Sarkis C; Pallàs M; Sanfeliu C
Mol Neurobiol; 2017 Sep; 54(7):5604-5619. PubMed ID: 27614878
[TBL] [Abstract][Full Text] [Related]
14. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
15. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles.
Li JG; Chu J; Barrero C; Merali S; Praticò D
Ann Neurol; 2014 Jun; 75(6):851-63. PubMed ID: 24644038
[TBL] [Abstract][Full Text] [Related]
17. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
[TBL] [Abstract][Full Text] [Related]
19. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
